Abstract
The advancement of systemic chemotherapy for colorectal carcinoma has improved a clinical response rate and expanded a possibility of resection, which we thought we could not have been operable at the initial visit. It also improved a prognosis of patients. We report here a case with liver resection of metastasis from rectal cancer followed by bevacizumab treatment.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Angiogenesis Inhibitors / administration & dosage*
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bevacizumab
-
Camptothecin / administration & dosage
-
Camptothecin / analogs & derivatives
-
Fluorouracil / administration & dosage
-
Hepatectomy*
-
Humans
-
Leucovorin / administration & dosage
-
Liver Neoplasms / secondary*
-
Liver Neoplasms / therapy*
-
Male
-
Middle Aged
-
Organoplatinum Compounds / administration & dosage
-
Rectal Neoplasms / pathology*
-
Rectal Neoplasms / surgery
-
Reoperation
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Organoplatinum Compounds
-
Bevacizumab
-
Leucovorin
-
Fluorouracil
-
Camptothecin
Supplementary concepts
-
Folfox protocol
-
IFL protocol